GeneLink, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
55/100
100
Valuation
40
Profitability
55
Growth
52
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNLKQ research report →
52-Week Range100% of range
Low $0.00
Current $0.00
High $0.00
Companywww.genelinkbio.com
GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements.
- CEO
- Bernard L. Kasten Jr.
- IPO
- 1998
- Employees
- 14
- HQ
- Orlando, FL, US
Price Chart
+0.00% · this period
Valuation
- Market Cap
- $10.60K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- 0.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 21.75%
- Op Margin
- -162.40%
- Net Margin
- -142.86%
- ROE
- 147.34%
- ROIC
- 902.77%
Growth & Income
- Revenue
- $2.14M · -54.40%
- Net Income
- $-3,051,747 · 20.32%
- EPS
- $-0.01 · 50.00%
- Op Income
- $-3,468,997
- FCF YoY
- 10.77%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -157.42
- Avg Volume
- 270
Get TickerSpark's AI analysis on GNLKQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GNLKQ Coverage
We haven't published any research on GNLKQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GNLKQ Report →